CARTELA AB has a total of 26 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and Sweden. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GINKGO BIOMEDICAL RES INST CO, ANAMAR MEDICAL AB and YAMAMOTO NOBUTO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Sweden | 4 | |
#4 | United Kingdom | 3 | |
#5 | Australia | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | United States | 2 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Medical preparations | |
#6 | Animal care | |
#7 | Measuring microorganism processes | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lundgren-Aakerlund Evy | 11 |
#2 | Gullberg Donald | 7 |
#3 | Lundgren-Akerlund Evy | 7 |
#4 | Kjellman Christian | 3 |
#5 | Lundgren-Ang Kerlund Evy | 1 |
#6 | Lundgren-Aekerlund Evy | 1 |
#7 | Lundgren-Kerlund Evy | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007099337A1 | Expansion and differentiation of mesenchymal stem cells | |
GB0625165D0 | Novel binding agents and uses thereof | |
GB0605738D0 | Novel diagnostic and therapeutic methods | |
GB0516571D0 | Polypeptides capable of binding an integrin I-domain. | |
WO2004089990A1 | New monoclonal antibody capable of binding integrin alpha 10 beta 1 | |
AU5435500A | An integrin heterodimer and an alpha subunit thereof | |
CA2324381A1 | An integrin heterodimer and a subunit thereof |